Glenmark Pharmaceuticals has informed about submission of media release titled ' Glenmark Pharmaceuticals receives ANDA approval for Hydrocortisone Valerate Ointment USP, 0.2%', which is self explanatory.
The above information is a part of company's filings submitted to BSE.